Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies Read More > December 1, 2020
Psychedelic-assisted therapy for functional neurological disorders: A theoretical framework and review of prior reports Read More > December 1, 2020
Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison Read More > December 1, 2020
Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System Read More > December 1, 2020
Rethinking enhancement substance use: A critical discourse studies approach Read More > November 30, 2020
Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine Read More > November 30, 2020
Combining Ketamine, Brain Stimulation (rTMS) and Mindfulness Therapy (TIMBER) for Opioid Addiction Read More > November 30, 2020
Is ketamine an appropriate alternative to ECT for patients with treatment resistant depression? A systematic review Read More > November 30, 2020
Corticosterone as a Potential Confounding Factor in Delineating Mechanisms Underlying Ketamine’s Rapid Antidepressant Actions Read More > November 30, 2020
